Cargando…
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases
We present the cases of three patients with severe, life-threatening coronavirus disease 2019 (COVID-19) who had failed to achieve substantial improvement on intial treatment. They subsequently received pulse therapy with methylprednisolone [1,000 mg/day intravenously (IV) for three consecutive days...
Autores principales: | Sheianov, Mikhail V, Udalov, Yurii D, Ochkin, Sergei S, Bashkov, Andrei N, Samoilov, Aleksandr S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343298/ https://www.ncbi.nlm.nih.gov/pubmed/32656044 http://dx.doi.org/10.7759/cureus.9038 |
Ejemplares similares
-
An Atypical Presentation of West Nile Virus With Successful Treatment After Plasma Exchange and Intravenous Immunoglobulin
por: Malone, Kevin, et al.
Publicado: (2022) -
Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension
por: Ehikioya, Eustace, et al.
Publicado: (2023) -
Giant Cell Arteritis With Chronic Bronchitis Successfully Treated With Tocilizumab
por: Ohta, Ryuichi, et al.
Publicado: (2023) -
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
por: Naik, Naveen B, et al.
Publicado: (2021) -
Development of a Three-Dimensionally Printed Ultrasound-Guided Peripheral Intravenous Catheter Phantom
por: Tan, Ting Xu, et al.
Publicado: (2021)